PRTK
Paratek Pharmaceuticals, Inc.
PRTK
PRTK
Delisted
PRTK was delisted on the 20th of September, 2023.
133 hedge funds and large institutions have $609M invested in Paratek Pharmaceuticals, Inc. in 2017 Q3 according to their latest regulatory filings, with 34 funds opening new positions, 48 increasing their positions, 33 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
8% more capital invested
Capital invested by funds: $564M → $609M (+$45.4M)
50% less funds holding in top 10
Funds holding in top 10: 6 → 3 (-3)
Holders
133
Holding in Top 10
3
Calls
$8.47M
Puts
$5.15M
Top Buyers
| 1 | +$19M | |
| 2 | +$16.8M | |
| 3 | +$8.6M | |
| 4 |
PAMU
Pictet Asset Management (UK)
London,
United Kingdom
|
+$7.91M |
| 5 |
Millennium Management
New York
|
+$7.86M |
Top Sellers
| 1 | -$12.8M | |
| 2 | -$12.3M | |
| 3 | -$11.6M | |
| 4 |
Balyasny Asset Management
Chicago,
Illinois
|
-$8.44M |
| 5 |
A
Abingworth
London,
United Kingdom
|
-$6.51M |